Alex Martínez‐Martí

Vall d'Hebron Institute of Oncology ORCID: 0000-0002-6714-9526

2

h-index

2

Publications

2,648

Citations

Publications

2 shown

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres , Alexander Drilon , Amélie Lusque +35 more

2019 Annals of Oncology 1292 citations

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip , Nasser K. Altorki , Caicun Zhou +18 more

2021 The Lancet 1356 citations

Frequent Co-Authors

Enriqueta Felip

Vall d'Hebron Institute of Oncology

Nasser K. Altorki

Cornell University

Caicun Zhou

Shanghai Pulmonary Hospital

Tibor Csőszi

Université Toulouse III - Paul Sabatier

Ihor Vynnychenko

Sumy State University

Oleksandr Goloborodko

National University Zaporizhzhia Polytechnic

Researcher Info

h-index: 2
Publications: 2
Citations: 2,648
Institution: Vall d'Hebron Institute of Oncology

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6714-9526

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.

Academic Output Over Time